Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lei Xu, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Lei Xu and Meenal Datta.
Connection Strength

1.232
  1. Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models. Sci Transl Med. 2021 Jul 14; 13(602).
    View in: PubMed
    Score: 0.249
  2. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma. Proc Natl Acad Sci U S A. 2019 02 05; 116(6):2210-2219.
    View in: PubMed
    Score: 0.210
  3. Anti-VEGF treatment improves neurological function in tumors of the nervous system. Exp Neurol. 2018 01; 299(Pt B):326-333.
    View in: PubMed
    Score: 0.191
  4. Rationally combining anti-VEGF therapy with radiation in NF2 schwannoma. J Rare Dis Res Treat. 2016; 1(2):51-55.
    View in: PubMed
    Score: 0.170
  5. Mathematical Model of Oxygen Transport in Tuberculosis Granulomas. Ann Biomed Eng. 2016 Apr; 44(4):863-72.
    View in: PubMed
    Score: 0.165
  6. Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery. Proc Natl Acad Sci U S A. 2015 Feb 10; 112(6):1827-32.
    View in: PubMed
    Score: 0.159
  7. Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages. Proc Natl Acad Sci U S A. 2016 Apr 19; 113(16):4470-5.
    View in: PubMed
    Score: 0.043
  8. Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival. Proc Natl Acad Sci U S A. 2016 Apr 19; 113(16):4476-81.
    View in: PubMed
    Score: 0.043
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.